Buyer Name: NHS England
Buyer Address: 7&8 Wellington Place, Leeds, UKE, LS1 4AP, United Kingdom
Contact Name: Jessica Gaucher-Thomspon
Contact Email: jessica.gaucher-thompson@nhs.net
Buyer Name: NHS England
Buyer Address: 7&8 Wellington Place, Leeds, UKE, LS1 4AP, United Kingdom
Contact Name: Jessica Gaucher-Thomspon
Contact Email: jessica.gaucher-thompson@nhs.net
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU),on behalf of NHS England Specialised Commissioning (referred to as the Authority) is inviting suitably qualified and experienced providers to express interest in the provision of Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes by responding to this accreditation process.<br/><br/>As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration five (5) years).<br/><br/>The deadline for submissions is12.00pm (noon) on Monday 8 December 2025.<br/><br/>The successful Providers are expected to be fully operational, providing services from 01 May 2026.
No linked documents found for this notice.
Lot Description: The key objective of this procurement is to commission Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes. Services will be commissioned across seven (7) geographical regions to serve the population of England, as outlined below:<br/><br/>Lot 1: London<br/>Lot 2: East of England<br/>Lot 3: South East<br/>Lot 4: South West<br/>Lot 5: Midlands <br/>Lot 6: North East and Yorkshire<br/>Lot 7: North West<br/><br/>Bidders are to note:<br/>- There is no restriction on the number of sites that may be commissioned.<br/>- Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.<br/><br/>Link to NHS England Regions:<br/>NHS England » Regional teams (https://www.england.nhs.uk/about/regional-area-teams/). <br/><br/>Inherited cancer predisposition syndromes are genetic conditions that increase the risk of developing one or more types of cancer. Scanning will be commissioned for three rare inherited cancer predisposition syndromes; Li-Fraumeni syndrome (LFS), constitutional mismatch repair deficiency syndrome (CMMRD) and rhabdoid tumour predisposition syndrome (RTPS). <br/><br/>Published clinical guidelines for these conditions recommend the use of regular whole-body MRI (WBMRI) with the aim of detecting cancers at an early stage. The provision of expanded capacity for WBMRI scanning aims to improve clinical care of individuals once an inherited cancer predisposition has been diagnosed.<br/><br/>Providers will:<br/>• Provide, interpret and report WB-MRI Scanning for the patient cohort described.<br/>• Provide, interpret, and report brain MRI Scanning (the first one with contrast when possible).<br/>• Establish effective pathways (including sharing results) with providers.<br/>• Be linked to regional genetic centres to allow continuity of care.<br/>• Facilitate communication with referrers including consultant clinical geneticists<br/>• Have capacity to plan and undertake WBMRI under general anaesthetic if re-quired.<br/>• Have information governance processes that permit sharing clinical and imaging data across organisations involved with providing a cancer surveillance service, and collection of clinical outcome and monitoring data.<br/>• Engage positively with associated patient support groups. <br/>• Ensure clear communication with Genetics Services and patients, to support patients to make decisions on where to access screening.<br/>• Work collaboratively with other organisations e.g. within imaging networks, to provide scanning and reporting capacity and expertise to meet the needs of their population including transition between paediatric and adult services.<br/>• Operate Quality Assessment processes according to CQC standards<br/>• Screening will be in addition to breast screening undertaken through the National VHRS Programme<br/>• Provide facilities will be in line with NHS guidance on Facilities for diagnostic imaging and interventional radiology.<br/>• Support continued educational initiatives for non-genetics healthcare professionals to improve expertise and understanding of cancer predisposition syndromes.<br/>• Liaise with partners across cancer alliances to support early diagnosis innovation opportunities<br/>• Ensure screening frequency will be in accordance with surveillance protocols.<br/><br/>Providers must be able to meet the requirements set out in this Competitive Process and deliver the contract in accordance with its terms.<br/><br/>To express interest and participate in the Competitive Process, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome Should Tenderers have any queries, or problems using the portal, they should contact the Helpdesk at:<br/><br/>Phone: 08000988201<br/>E-mail: support-health@atamis.co.uk<br/><br/>The closing date for completed Competitive Process responses is 12:00pm (noon), on Monday 8 December 2025.<br/><br/>Atamis Project reference C310713.<br/><br/>The contract duration is for three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration five (5) years).<br/><br/>This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to<br/>the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply.
Lot 1 Status: active
Lot 1 Has Options: Yes
Lot 1 Options: The contract duration is for three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration five (5) years).
Lot 1 Value: GBP 3,000,000.00
{
"buyer": {
"id": "GB-FTS-118033",
"name": "NHS England"
},
"date": "2025-10-27T08:56:29Z",
"id": "068396-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-05d3d5",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Leeds",
"postalCode": "LS1 4AP",
"region": "UKE",
"streetAddress": "7\u00268 Wellington Place"
},
"contactPoint": {
"email": "jessica.gaucher-thompson@nhs.net",
"name": "Jessica Gaucher-Thomspon",
"url": "https://health-family.force.com/s/Welcome"
},
"details": {
"buyerProfile": "https://www.england.nhs.uk//",
"classifications": [
{
"description": "Body governed by public law",
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "https://www.england.nhs.uk//"
},
"id": "GB-FTS-118033",
"identifier": {
"legalName": "NHS England"
},
"name": "NHS England",
"roles": [
"buyer"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Derby",
"postalCode": "DE1 3QT",
"streetAddress": "Cardinal Square, 10 Nottingham Road"
},
"details": {
"url": "https://www.ardengemcsu.nhs.uk/"
},
"id": "GB-FTS-141301",
"identifier": {
"legalName": "NHS Arden and Greater East Midlands Commissioning Support Unit"
},
"name": "NHS Arden and Greater East Midlands Commissioning Support Unit",
"roles": [
"reviewBody"
]
}
],
"tag": [
"tender"
],
"tender": {
"awardPeriod": {
"startDate": "2025-10-27T08:00:00Z"
},
"bidOpening": {
"date": "2025-10-27T08:00:00Z"
},
"classification": {
"description": "Health services",
"id": "85100000",
"scheme": "CPV"
},
"communication": {
"atypicalToolUrl": "https://health-family.force.com/s/Welcome"
},
"coveredBy": [
"GPA"
],
"description": "NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU),on behalf of NHS England Specialised Commissioning (referred to as the Authority) is inviting suitably qualified and experienced providers to express interest in the provision of Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes by responding to this accreditation process.\u003cbr/\u003e\u003cbr/\u003eAs a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration five (5) years).\u003cbr/\u003e\u003cbr/\u003eThe deadline for submissions is12.00pm (noon) on Monday 8 December 2025.\u003cbr/\u003e\u003cbr/\u003eThe successful Providers are expected to be fully operational, providing services from 01 May 2026.",
"hasRecurrence": false,
"id": "ocds-h6vhtk-05d3d5",
"items": [
{
"additionalClassifications": [
{
"description": "Health services",
"id": "85100000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UK"
}
],
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"contractPeriod": {
"durationInDays": 1800
},
"description": "The key objective of this procurement is to commission Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes. Services will be commissioned across seven (7) geographical regions to serve the population of England, as outlined below:\u003cbr/\u003e\u003cbr/\u003eLot 1: London\u003cbr/\u003eLot 2: East of England\u003cbr/\u003eLot 3: South East\u003cbr/\u003eLot 4: South West\u003cbr/\u003eLot 5: Midlands \u003cbr/\u003eLot 6: North East and Yorkshire\u003cbr/\u003eLot 7: North West\u003cbr/\u003e\u003cbr/\u003eBidders are to note:\u003cbr/\u003e- There is no restriction on the number of sites that may be commissioned.\u003cbr/\u003e- Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.\u003cbr/\u003e\u003cbr/\u003eLink to NHS England Regions:\u003cbr/\u003eNHS England \u00bb Regional teams (https://www.england.nhs.uk/about/regional-area-teams/). \u003cbr/\u003e\u003cbr/\u003eInherited cancer predisposition syndromes are genetic conditions that increase the risk of developing one or more types of cancer. Scanning will be commissioned for three rare inherited cancer predisposition syndromes; Li-Fraumeni syndrome (LFS), constitutional mismatch repair deficiency syndrome (CMMRD) and rhabdoid tumour predisposition syndrome (RTPS). \u003cbr/\u003e\u003cbr/\u003ePublished clinical guidelines for these conditions recommend the use of regular whole-body MRI (WBMRI) with the aim of detecting cancers at an early stage. The provision of expanded capacity for WBMRI scanning aims to improve clinical care of individuals once an inherited cancer predisposition has been diagnosed.\u003cbr/\u003e\u003cbr/\u003eProviders will:\u003cbr/\u003e\u2022\tProvide, interpret and report WB-MRI Scanning for the patient cohort described.\u003cbr/\u003e\u2022\tProvide, interpret, and report brain MRI Scanning (the first one with contrast when possible).\u003cbr/\u003e\u2022\tEstablish effective pathways (including sharing results) with providers.\u003cbr/\u003e\u2022\tBe linked to regional genetic centres to allow continuity of care.\u003cbr/\u003e\u2022\tFacilitate communication with referrers including consultant clinical geneticists\u003cbr/\u003e\u2022\tHave capacity to plan and undertake WBMRI under general anaesthetic if re-quired.\u003cbr/\u003e\u2022\tHave information governance processes that permit sharing clinical and imaging data across organisations involved with providing a cancer surveillance service, and collection of clinical outcome and monitoring data.\u003cbr/\u003e\u2022\tEngage positively with associated patient support groups. \u003cbr/\u003e\u2022\tEnsure clear communication with Genetics Services and patients, to support patients to make decisions on where to access screening.\u003cbr/\u003e\u2022\tWork collaboratively with other organisations e.g. within imaging networks, to provide scanning and reporting capacity and expertise to meet the needs of their population including transition between paediatric and adult services.\u003cbr/\u003e\u2022\tOperate Quality Assessment processes according to CQC standards\u003cbr/\u003e\u2022\tScreening will be in addition to breast screening undertaken through the National VHRS Programme\u003cbr/\u003e\u2022\tProvide facilities will be in line with NHS guidance on Facilities for diagnostic imaging and interventional radiology.\u003cbr/\u003e\u2022\tSupport continued educational initiatives for non-genetics healthcare professionals to improve expertise and understanding of cancer predisposition syndromes.\u003cbr/\u003e\u2022\tLiaise with partners across cancer alliances to support early diagnosis innovation opportunities\u003cbr/\u003e\u2022\tEnsure screening frequency will be in accordance with surveillance protocols.\u003cbr/\u003e\u003cbr/\u003eProviders must be able to meet the requirements set out in this Competitive Process and deliver the contract in accordance with its terms.\u003cbr/\u003e\u003cbr/\u003eTo express interest and participate in the Competitive Process, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome Should Tenderers have any queries, or problems using the portal, they should contact the Helpdesk at:\u003cbr/\u003e\u003cbr/\u003ePhone: 08000988201\u003cbr/\u003eE-mail: support-health@atamis.co.uk\u003cbr/\u003e\u003cbr/\u003eThe closing date for completed Competitive Process responses is 12:00pm (noon), on Monday 8 December 2025.\u003cbr/\u003e\u003cbr/\u003eAtamis Project reference C310713.\u003cbr/\u003e\u003cbr/\u003eThe contract duration is for three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration five (5) years).\u003cbr/\u003e\u003cbr/\u003eThis is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to\u003cbr/\u003ethe Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply.",
"hasOptions": true,
"hasRenewal": false,
"id": "1",
"options": {
"description": "The contract duration is for three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration five (5) years)."
},
"status": "active",
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"value": {
"amount": 3000000.0,
"currency": "GBP"
}
}
],
"mainProcurementCategory": "services",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"status": "active",
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "https://health-family.force.com/s/Welcome",
"submissionTerms": {
"bidValidityPeriod": {
"durationInDays": 150
},
"languages": [
"en"
]
},
"tenderPeriod": {
"endDate": "2025-12-08"
},
"title": "Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes",
"value": {
"amount": 3000000.0,
"currency": "GBP"
}
}
}